Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

The total economic output of Biotech in South San Francisco is $133.5 billion, supporting more than 250,000 workers, ...

Nutraceuticals in India are gaining popularity due to rising health awareness, an increase in lifestyle diseases, and a shift ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

After the slides are generated, you can edit them just like any other presentation in Google Slides, export them for PowerPoint, and continue to edit ... AI-generated text and images, and tools for ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

This app uses Apple Intelligence to generate custom images on your device. You can choose from a list of suggested prompts, or you can enter your own description of an image and your iPhone will ...

The National Medical Commission has launched an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the Uniform Code for Pharmaceutical Practices. AbbVie spent over a ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...